1. Home
  2. AURA vs DMAA Comparison

AURA vs DMAA Comparison

Compare AURA & DMAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • DMAA
  • Stock Information
  • Founded
  • AURA 2007
  • DMAA 2024
  • Country
  • AURA United States
  • DMAA United States
  • Employees
  • AURA N/A
  • DMAA N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • DMAA
  • Sector
  • AURA Health Care
  • DMAA
  • Exchange
  • AURA Nasdaq
  • DMAA NYSE
  • Market Cap
  • AURA 396.8M
  • DMAA 341.5M
  • IPO Year
  • AURA 2021
  • DMAA 2025
  • Fundamental
  • Price
  • AURA $6.49
  • DMAA $10.21
  • Analyst Decision
  • AURA Strong Buy
  • DMAA
  • Analyst Count
  • AURA 6
  • DMAA 0
  • Target Price
  • AURA $22.33
  • DMAA N/A
  • AVG Volume (30 Days)
  • AURA 217.8K
  • DMAA 43.3K
  • Earning Date
  • AURA 08-07-2025
  • DMAA 01-01-0001
  • Dividend Yield
  • AURA N/A
  • DMAA N/A
  • EPS Growth
  • AURA N/A
  • DMAA N/A
  • EPS
  • AURA N/A
  • DMAA N/A
  • Revenue
  • AURA N/A
  • DMAA N/A
  • Revenue This Year
  • AURA N/A
  • DMAA N/A
  • Revenue Next Year
  • AURA N/A
  • DMAA N/A
  • P/E Ratio
  • AURA N/A
  • DMAA N/A
  • Revenue Growth
  • AURA N/A
  • DMAA N/A
  • 52 Week Low
  • AURA $4.35
  • DMAA $9.95
  • 52 Week High
  • AURA $12.38
  • DMAA $10.27
  • Technical
  • Relative Strength Index (RSI)
  • AURA 59.68
  • DMAA N/A
  • Support Level
  • AURA $5.96
  • DMAA N/A
  • Resistance Level
  • AURA $6.68
  • DMAA N/A
  • Average True Range (ATR)
  • AURA 0.36
  • DMAA 0.00
  • MACD
  • AURA 0.01
  • DMAA 0.00
  • Stochastic Oscillator
  • AURA 97.70
  • DMAA 0.00

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About DMAA DRUGS MADE IN AMER ACQUISITION CORP

Drugs Made In America Acquisition Corp is a blank check company.

Share on Social Networks: